TMC Fertility has been shortlisted to receive the International Business Review ASEAN Awards 2022 for Innovative Technology in the Healthcare Sector for Genetic Therapy in Fertility Treatments, in recognition of its advanced medical and technological capabilities and expertise.
Established in 1994, TMC Fertility is one of the pioneers of Malaysia’s fertility industry, offering a wide range of services such as Intra-uterine insemination (IUI), In-vitro fertilisation (IVF) and Intra-cytoplasmic sperm injection (ICSI).
CEO Irene Kwan emphasises that the team is constantly striving for excellence and innovation as it strives to make its clients’ dreams of becoming parents a reality.
Through technology such as PGT-A (preimplantation genetic testing) for the selection of the best embryos for implantation, micro-RNA to determine the best window of implantation and microfluidic sperm selection for the best selection of sperms, TMC Fertility is able to make better decisions on the best option of treatment, thus helping patients to increase their success rates.
This year, TMC Fertility has pioneered another breakthrough in fertility treatments, utilising pharmacogenomics in IVF to eliminate the guessing game in a couple’s fertility journey.
For its contributions to the fertility industry, TMC Fertility has been shortlisted to receive the International Business Review ASEAN Awards 2022.
Join us for the grand celebration this year!
How do you ensure quality care and excellence in service? Through tireless commitment to deliver the best results. Irene Kwan, the CEO of TMC Fertility, explains that they are now exploring the use of Artificial Intelligence (AI) to improve IVF success rates with greater accuracy, reducing time-to-pregnancy and making the treatment more affordable in the process. For the reasons above, TMC Fertility is shortlisted to receive the International Business Review ASEAN Awards 2020 for Innovative Technology in the Healthcare Sector.
Boasting an impressive track record, years of experience in fertility services and world-class facilities, TMC Fertility is well underway to become one of the region’s leading fertility treatment centres. CEO Irene Kwan shares that TMC Fertility serves clients from other parts of the world. For its commitment to provide treatment solutions, and for pioneering key innovations in the industry, TMC Fertility is shortlisted to receive the International Business Review ASEAN Awards 2020 for Innovative Technology in the Healthcare Sector.
As one of the pioneers of fertility services in Malaysia, TMC Fertility has helped numerous families improve their chances at starting a family. The company boasts impressive success rates in clinical pregnancies of close to 66%, comparable to that of other world-renowned fertility centres. CEO Irene Kwan explains that this is possible due to the company’s dedication to continuous improvement and an emphasis on strategic innovations and technologies. This is also the reason TMC Fertility has been shortlisted to receive the International Business Review ASEAN Awards 2020 for Innovative Technology in the Healthcare Sector for Assisted Reproductive Technology (ART) Solutions. #IBRAA2020
Did you know that dental health plays a role in boosting fertility rates? According to Irene Kwan, CEO of TMC Fertility, in addition to adopting and introducing innovative solutions in In vitro fertilisation (IVF), the company also provides complementary treatments in traditional Chinese medicine, dentistry and dietary counselling services – all of which contribute to positive experiences and results for their patients. This commitment to quality care and innovation is why TMC Fertility is shortlisted to receive the International Business Review ASEAN Awards 2020 for Innovative Technology in the Healthcare Sector for Assisted Reproductive Technology (ART) Solutions.
